Medtronic diabetes patient engagement program to offer game-based blood sugar tracking with rewards

Medtronic began the program after a survey found that 88% of users were interested in more effectively managing their diabetes through a program teaching them how to optimize their therapy. (Clem Onojeghuo/Unsplash)

Medtronic launched a new patient engagement program that aims to use game-design elements to encourage people with diabetes to better track their blood glucose levels for improved health outcomes.

The Inner Circle program focuses on helping patients spend more time in an optimal glycemic range of 70-180 mg/dL, by providing personalized challenges and achievements. It also includes a public forum for tracking progress and sharing management strategies.

“Diabetes is unrelenting, and we are committed to innovating in new ways—beyond technology—to provide inspiration, motivation and education to help people with diabetes on their journey to better health,” Medtronic’s Louis Dias, chief patient officer of its diabetes group, said in a statement.

FREE DAILY NEWSLETTER

Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

Eligible patients will be invited to enroll once they begin using the MiniMed 670G insulin pump or the Guardian Connect continuous glucose monitoring system.

RELATED: FDA expands use of Medtronic’s ‘artificial pancreas,’ approves Eversense’s implantable CGM system

Medtronic decided to begin the program following a patient survey that found 88% of MiniMed 670G users were interested in a program that could help them more effectively manage their diabetes by learning how to optimize their therapy.

RELATED: Medtronic rolls out updated iPro2 glucose-monitoring app, expands relationship with Nutrino

In one of the company’s investor day presentations in New York City earlier this summer, Hooman Hakami, executive VP and president of the diabetes group, described (PDF) how patients would be able to earn potentially redeemable points for the amount of time they spend in the optimal range.

Hakami said this gamification and tracking could offer clinical and economic benefits for health systems, and possibly provide opportunities for employers. In the future, Medtronic aims to offer real-time coaching alongside its personalized guidance.

Suggested Articles

What the NASH field needs, says Genfit CEO Pascal Prigent, is something like the Hb1Ac test for diabetes.

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Exact Sciences received an FDA breakthrough designation for its liver cancer blood test as it finalized its $2.8 billion merger with Genomic Health.